Clinical Trial

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The aim of this clinical trials is to evaluate the safety and efficacy of intravitreal injection of GMP-compliant BM-MSC-derived sEVs in patients with retinitis pigmentosa.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-02-02; most recent amendment 2025-05-12.
Status change: Not Yet Recruiting → Recruiting 2024-05-28
Trial Details
NCT Number NCT06242379
Lead Sponsor Mahidol University
Conditions Retinitis Pigmentosa
Enrollment 15 participants
Start Date 2024-05-23
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-15